The MOnitoring Resynchronization DEvices and CARdiac PatiEnts (MORE-CARE) Randomized Controlled Trial: Phase 1 Results on Dynamics of Early Intervention with Remote Monitoring
Overview
Authors
Affiliations
Background: Remote monitoring (RM) in patients with advanced heart failure and cardiac resynchronization therapy defibrillators (CRT-D) may reduce delays in clinical decisions by transmitting automatic alerts. However, this strategy has never been tested specifically in this patient population, with alerts for lung fluid overload, and in a European setting.
Objective: The main objective of Phase 1 (presented here) is to evaluate if RM strategy is able to reduce time from device-detected events to clinical decisions.
Methods: In this multicenter randomized controlled trial, patients with moderate to severe heart failure implanted with CRT-D devices were randomized to a Remote group (with remote follow-up and wireless automatic alerts) or to a Control group (with standard follow-up without alerts). The primary endpoint of Phase 1 was the delay between an alert event and clinical decisions related to the event in the first 154 enrolled patients followed for 1 year.
Results: The median delay from device-detected events to clinical decisions was considerably shorter in the Remote group compared to the Control group: 2 (25(th)-75(th) percentile, 1-4) days vs 29 (25(th)-75(th) percentile, 3-51) days respectively, P=.004. In-hospital visits were reduced in the Remote group (2.0 visits/patient/year vs 3.2 visits/patient/year in the Control group, 37.5% relative reduction, P<.001). Automatic alerts were successfully transmitted in 93% of events occurring outside the hospital in the Remote group. The annual rate of all-cause hospitalizations per patient did not differ between the two groups (P=.65).
Conclusions: RM in CRT-D patients with advanced heart failure allows physicians to promptly react to clinically relevant automatic alerts and significantly reduces the burden of in-hospital visits.
Trial Registration: Clinicaltrials.gov NCT00885677; http://clinicaltrials.gov/show/NCT00885677 (Archived by WebCite at http://www.webcitation.org/6IkcCJ7NF).
Recent Advances in Cardiac Resynchronization Therapy: Current Treatment and Future Direction.
Siddiqui A, Tasouli-Drakou V, Ringor M, DiCaro M, Yee B, Lei K J Clin Med. 2025; 14(3).
PMID: 39941560 PMC: 11818169. DOI: 10.3390/jcm14030889.
Tan S, Sumner J, Wang Y, Yip A NPJ Digit Med. 2024; 7(1):192.
PMID: 39025937 PMC: 11258279. DOI: 10.1038/s41746-024-01182-w.
Contemporary Advances in Cardiac Remote Monitoring: A Comprehensive, Updated Mini-Review.
Preda A, Falco R, Tognola C, Carbonaro M, Vargiu S, Gallazzi M Medicina (Kaunas). 2024; 60(5).
PMID: 38793002 PMC: 11122881. DOI: 10.3390/medicina60050819.
Cardoso I, Silva Cunha P, Laranjo S, Grazina A, Miguel Viegas J, Portugal G J Innov Card Rhythm Manag. 2023; 14(9):5576-5581.
PMID: 37781719 PMC: 10540879. DOI: 10.19102/icrm.2023.14093.
Ziacchi M, Molon G, Giudici V, Botto G, Viscusi M, Brasca F J Clin Med. 2023; 12(17).
PMID: 37685593 PMC: 10488122. DOI: 10.3390/jcm12175528.